Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9618 |
High Similarity |
NPD5124 |
Phase 1 |
0.9618 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.854 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8394 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8207 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.8148 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8143 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.812 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8102 |
Intermediate Similarity |
NPD3225 |
Approved |
0.8092 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8043 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7974 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7922 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7905 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7887 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7871 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7823 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7823 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7815 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.777 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7762 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7748 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7748 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.774 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.773 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7727 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7687 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7669 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7662 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7655 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7654 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7643 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7622 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7582 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7552 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7535 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7535 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7517 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD6799 |
Approved |
0.75 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.745 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7434 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7431 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD4140 |
Approved |
0.74 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7376 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7357 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7342 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7286 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7262 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7262 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7261 |
Intermediate Similarity |
NPD920 |
Approved |
0.726 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD1243 |
Approved |
0.725 |
Intermediate Similarity |
NPD37 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7237 |
Intermediate Similarity |
NPD5762 |
Approved |
0.723 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7226 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7222 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7218 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7208 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7181 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD1203 |
Approved |
0.716 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7134 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7124 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7105 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7095 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1608 |
Approved |
0.707 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7041 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD290 |
Approved |
0.7037 |
Intermediate Similarity |
NPD4433 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7035 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6502 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7013 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD1778 |
Approved |
0.6987 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6981 |
Remote Similarity |
NPD1512 |
Approved |
0.6974 |
Remote Similarity |
NPD6651 |
Approved |
0.6964 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD3226 |
Approved |
0.6951 |
Remote Similarity |
NPD2415 |
Discontinued |
0.6946 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6944 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6937 |
Remote Similarity |
NPD7427 |
Discontinued |
0.6928 |
Remote Similarity |
NPD919 |
Approved |
0.6927 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD2800 |
Approved |
0.6918 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6918
|
Remote Similarity |
NPD3685 |
Discontinued |